DocGo (DCGO) Q2 2026: 19% Organic Revenue Growth Amid Strategic Acquisition and Margin Pressure
DocGo delivered robust organic revenue growth despite a winding down of legacy migrant programs, driven by strength in virtual and mobile health services alongside record transportation volumes. The pending acquisition of Hicuity Health marks a strategic leap toward integrated virtual and in-home care delivery, although margin pressures and wider adjusted EBITDA losses highlight ongoing operational challenges. Investors should monitor integration progress and margin recovery as key drivers of DocGo’s path to profitability.
Summary
- Strategic Expansion: Acquisition of Hicuity Health positions DocGo to offer a comprehensive virtual and in-home care platform.
- Operational Momentum: Record volumes across all major segments underpin 19% organic revenue growth ex-migrant programs.
- Margin and Profitability Challenges: Adjusted EBITDA loss widened, reflecting margin headwinds and integration costs despite cost-cutting efforts.
Business Overview
DocGo is a technology-enabled healthcare provider specializing in mobile health services, medical transportation, and virtual care across the United States. The company generates revenue primarily through two segments: Medical Transportation Services and Mobile Health Services, which includes virtual care, remote patient monitoring (RPM), mobile phlebotomy, and care gap closure programs. Its business model leverages proprietary technology platforms to deliver healthcare services in the home, hospital, and community settings, targeting partnerships with health systems, payers, and clinical laboratories.
Performance Analysis
DocGo’s total revenue for Q2 2026 was $73.4 million, down from $80.4 million year-over-year, driven entirely by the wind-down of migrant-related programs that accounted for $18.8 million in revenue in Q2 2025. Excluding these legacy programs, the company achieved a strong 19% organic revenue growth, supported by contributions from the SteadyMD acquisition and growth in core business lines. Medical Transportation Services revenue rose to $52 million, the highest quarterly figure in company history, reflecting 15% volume growth and strong demand in key markets such as New York, Texas, and Tennessee. Mobile Health Services revenue was $21.4 million, down from $30.8 million, but excluding migrant programs, it surged 78%, driven by care gap closures, remote patient monitoring, mobile phlebotomy, and SteadyMD inclusion.
Despite revenue growth, DocGo’s adjusted gross margin declined slightly to 30.5% from 31.6% the prior year, impacted by elevated fuel costs and higher-than-expected hourly wages in medical transportation. Mobile Health Services gross margin softened to 27%, reflecting SteadyMD’s aggressive hiring and seasonal volume anticipation, though underlying margin improvements were evident in non-migrant lines. Adjusted EBITDA loss widened modestly to $6.3 million from $6.1 million, despite $4.5 million annualized SG&A savings from workforce reductions and ongoing AI-driven efficiency programs expected to yield $6 million in annual savings when fully implemented.
- Volume Growth Across Business Lines: Record increases in transportation, mobile phlebotomy, cardiac monitoring, and virtual care reflect strong demand.
- Margin Pressure from Cost Inflation: Fuel price increases and labor costs constrained transport margins, while SteadyMD’s margin dilution reflects growth investments.
- Efficiency Initiatives Underway: AI-driven automation and cost-cutting efforts are beginning to reduce operating expenses and improve operational leverage.
Overall, DocGo demonstrated solid operational execution and revenue momentum, but margin pressure and integration costs temper near-term profitability prospects.
Executive Commentary
"The continued evolution of our company into the premier provider of virtual, remote, and in-home healthcare at any address took a major leap forward with our pending acquisition of virtual care provider Hicuity Health... This solidifies our company’s unique position to bridge patient care across the entire continuum - from the hospital to the home."
Lee Bienstock, CEO of DocGo
"Our cost cutting initiatives progressed during the quarter, with more than four million dollars of estimated annual costs removed from SG&A... We believe that the Company will achieve a positive adjusted EBITDA run rate as we exit the year and head into 2027."
Norm Rosenberg, CFO of DocGo
Strategic Positioning
1. Acquisition of Hicuity Health Enhances Virtual and Acute Care Capabilities
DocGo’s acquisition of Hicuity Health, a provider of acute and critical care telemedicine services generating $65 million in trailing 12-month revenue, expands its virtual care footprint into hospital systems and post-acute settings. The integration aims to unify proprietary technology platforms, enabling a seamless match of clinical resources to patient needs across care settings. This move positions DocGo to offer a differentiated, end-to-end care platform bridging hospital and home, a critical advantage as healthcare shifts toward value-based, longitudinal care models.
2. Technology-Driven Efficiency Programs Target $6 Million Annual Savings
DocGo is aggressively deploying AI and automation tools across multiple business lines to streamline patient communications, order processing, and clinical documentation. For example, an AI communications agent now handles 60% of inbound patient calls and all outbound scheduling in the mobile phlebotomy business, dramatically reducing labor costs. With over 10 efficiency programs active and 20 more planned, these initiatives are central to improving margins and scaling operations cost-effectively.
3. Strengthening Core Segments with Focused Growth and Cross-Selling
Record volumes in medical transportation and mobile health services reflect sustained demand and successful market penetration. DocGo is leveraging its expanded platform to cross-sell services such as mobile phlebotomy, remote patient monitoring, and care gap closure to existing health system and payer partners. The new contract with a major national health plan in Pennsylvania exemplifies strategic expansion in insurance partnerships.
4. Margin Recovery Hinges on Wage Management and Fuel Cost Control
While adjusted gross margins declined modestly, DocGo is focused on reducing overtime rates, which fell to 8.1%, and mitigating fuel price impacts. The company anticipates margin normalization in mobile health as SteadyMD’s hiring stabilizes and higher-margin service lines gain share. Margin trajectory will be a key performance indicator for investors watching DocGo’s path to profitability.
5. Balance Sheet Strengthened Through Debt Financing and Capital Allocation
The acquisition financing includes assuming approximately $52 million of Hicuity debt, now maturing in 2029, and a commitment from Perceptive Advisors for up to $50 million of additional debt financing. This enhanced liquidity supports growth investments and operational flexibility. Meanwhile, cash balances declined to $48.1 million, reflecting ongoing investment and working capital needs, underscoring the importance of cash flow management.
Key Considerations
DocGo’s Q2 results and strategic moves highlight a healthcare services company evolving into a technology-enabled, vertically integrated care provider. Investors should weigh the following considerations:
- Integration Execution: Successful assimilation of Hicuity Health’s operations and clinical teams is critical for realizing synergies and cross-selling opportunities.
- Margin Improvement Path: Monitoring the impact of cost-cutting initiatives and efficiency programs on gross margins and adjusted EBITDA will be essential.
- Regulatory Environment for RPM: Potential CMS reimbursement changes for remote patient monitoring pose limited risk given DocGo’s emphasis on chronic care management and telemetry monitoring.
- Revenue Growth Sustainability: Organic growth of 5% excluding acquisitions and legacy program wind-down signals core business health but requires continued execution in competitive markets.
- Capital Structure and Liquidity: The new debt facilities provide financial flexibility but also increase leverage, necessitating disciplined cash flow management.
Risks
DocGo faces risks from integration complexities, potential delays in regulatory approvals for the acquisition, and margin pressures from labor and fuel cost inflation. The company’s adjusted EBITDA guidance was lowered, reflecting these headwinds. Additionally, reimbursement policy changes, particularly around remote patient monitoring, could affect revenue streams, though management believes their focus on chronic care management mitigates this risk.
Forward Outlook
For Q3 2026, DocGo expects:
- Revenue growth to continue with seasonal increases in virtual care and care gap closure services.
- Sequential improvement in adjusted EBITDA loss as cost savings and margin improvements materialize.
For full-year 2026, the company narrowed revenue guidance to $305 million to $310 million, excluding contributions from the Hicuity acquisition. Adjusted EBITDA loss guidance was widened to a range of $17 million to $22 million, reflecting slower-than-expected margin recovery and integration costs. Management anticipates exiting the year at a profitable run rate.
Key factors highlighted include continued revenue growth, margin trajectory improvement, and ongoing SG&A reductions through workforce optimization and vendor repricing.
Takeaways
DocGo’s Q2 2026 results reflect a company in transition, balancing strong organic growth and strategic expansion against margin and profitability challenges. The acquisition of Hicuity Health is a pivotal step toward building a comprehensive care delivery platform that spans hospital to home, leveraging technology and clinical integration.
- Revenue Growth Anchored by Core Business: Excluding legacy migrant programs, 19% revenue growth driven by medical transportation and mobile health services confirms market demand and operational strength.
- Operational Efficiencies Key to Margin Recovery: AI-driven automation and cost-cutting initiatives are beginning to reduce expenses, but margin pressure from wages and fuel costs remains significant.
- Integration and Execution Will Define Profitability Trajectory: Realizing synergies from the Hicuity acquisition and scaling cross-selling opportunities will be critical for achieving profitability and improving investor confidence.
Conclusion
DocGo’s second quarter underscores its evolution into a technology-enabled healthcare platform with promising growth prospects fueled by strategic acquisitions and operational innovation. However, margin pressures and wider adjusted EBITDA losses highlight the need for disciplined execution and cost management. The company’s ability to integrate Hicuity Health and realize efficiency gains will be pivotal in driving sustainable profitability.
Industry Read-Through
DocGo’s results illustrate broader healthcare industry trends toward integrated virtual and in-home care delivery, emphasizing the importance of technology-enabled platforms that bridge hospital and home settings. The company’s experience with reimbursement uncertainty in remote patient monitoring reflects sector-wide regulatory risks that providers must navigate. DocGo’s AI-driven efficiency initiatives and multi-state clinical integration offer a blueprint for scalability and margin improvement relevant to peers pursuing telehealth and mobile health expansion. Investors should watch how these dynamics unfold as healthcare delivery continues to shift toward value-based, patient-centric models.